PDCD1 and urothelial carcinoma: A study evaluating general cutaneous side effects of anti‐PD‐1 therapy reported 11 patients with BP; primary tumors were either melanoma (5), non‐small cell lung carcinoma (2), urothelial carcinoma (2), or head and neck squamous cell carcinoma (1).10